Radcliffe Capital Management »

Rocket Pharmaceuticals shares owned by Radcliffe Capital Management

Quarter-by-quarter ownership of Rocket Pharmaceuticals (RCKTW) shares owned by Radcliffe Capital Management from 13F filings

Historical chart of Radcliffe Capital Management investment in Rocket Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rocket Pharmaceuticals held by Radcliffe Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rocket Pharmaceuticals by Radcliffe Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $15k 86k 0.17

More positions owned by Radcliffe Capital Management

Alteryx Conv (Principal)
Spotify Technology Conv (Principal)
Magnite Conv (Principal)
Alteryx Conv (Principal)
Compass Digital Acquisition Corp Common Stock (CDAQ)
DocuSign Conv (Principal)
Prospect Capital Corp Conv (Principal)
Ares Acquisition Corp Common Stock
Churchill Capital Corp VII Common Stock (CVII)
Ares Acquisition Corp II Common Stock (AACT)
Apollo Strategic Growth Capital II Common Stock
Globus Medical Conv (Principal)
Screaming Eagle Acquisition Corp Common Stock (SCRM)
Enphys Acquisition Corp Common Stock (NFYS)
CF Acquisition Corp IV Common Stock

View all positions for Radcliffe Capital Management

Top funds holding Rocket Pharmaceuticals

Walleye Trading Advisors
Fort Baker Capital Management
Citadel Advisors
Jpmorgan Chase & Co
LMR Partners
Walleye Trading
Cowen And Company
Skaana Management
Ancora Advisors

View all funds holding Rocket Pharmaceuticals